Screener
Oric Pharmaceuticals, Inc. ORIC Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The source filing: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204047
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $56,396 | $45,669 |
| Short-term investments | 225,536 | 235,819 |
| Prepaid expenses and other current assets | 8,301 | 6,978 |
| Total current assets | 290,233 | 288,466 |
| Long-term investments | 137,779 | 110,762 |
| Property and equipment, net | 2,147 | 2,415 |
Item 1. Financial Statements.
FAQ
- What is Oric Pharmaceuticals, Inc.'s short-term investments?
- Oric Pharmaceuticals, Inc. (ORIC) reported short-term investments of $225.54M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s short-term investments changed year-over-year?
- Oric Pharmaceuticals, Inc.'s short-term investments increased by 46.1% year-over-year, from $154.39M to $225.54M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s short-term investments?
- Over 5 years (2020 to 2025), Oric Pharmaceuticals, Inc.'s short-term investments has grown at a 1.9% compound annual growth rate (CAGR), from $215.15M to $235.82M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Oric Pharmaceuticals, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude